Akums Drugs & Pharmaceuticals Ltd Analyst Rating
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts offering long term price targets for Akums Drugs & Pharmaceuticals Ltd. An average target of ₹840
Source: S&P Global Market Intelligence
Akums Drugs & Pharmaceuticals Ltd Share analysis
Akums Drugs & Pharmaceuticals Ltd price forecast by 1 analysts
Upside of32.76%
High
₹840
Target
₹840.00
Low
₹840
Akums Drugs & Pharmaceuticals Ltd target price ₹840, a slight upside of 32.76% compared to current price of ₹623.85. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Akums Drugs & Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Akums Drugs & Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Akums Drugs & Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹621.15Day's Price Range₹634.9552 Week's Low
52 Week's High
₹530.0552-Week Price Range₹1,175.9
| Returns % | |
| 1 Month Return | + 10.46 % |
| 3 Month Return | -30.91 % |
| 1 Year Return | -20.54 % |
| Market Stats | |
| Previous Close | ₹632.70 |
| Open | ₹623.85 |
| Volume | 81.85K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹9,958.32Cr |
Akums Drugs & Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 32.9 |
| PEG Ratio | 1.09 |
| Market Cap | ₹9,958.32 Cr |
| P/B Ratio | 0 |
| EPS | 0 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 91.28 |
Akums Drugs & Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹9,958.32 Cr | -4.11% | 0.00 | ₹97 Cr | ₹4,178 Cr | |
| NA | ₹196.44 Cr | 79.21% | 0.56 | NA | NA | |
| NA | ₹51.31 Cr | 6.28% | 0.68 | NA | NA | |
| NA | ₹1,160.76 Cr | 5.81% | 0.68 | -₹25 Cr | ₹335 Cr | |
| NA | ₹12.55 Cr | 52.8% | -0.10 | NA | NA |
Akums Drugs & Pharmaceuticals Ltd Mutual Fund Holdings
About Akums Drugs & Pharmaceuticals Ltd
Share Price: ₹623.85 per share as on 20 Jan, 2025 02:04 PM
Market Capitalisation: ₹9,958.32Cr as of today
Revenue: ₹1,033.09Cr as on September 2024 (Q3 24)
Net Profit: ₹66.65Cr as on September 2024 (Q3 24)
Listing date: 06 Aug, 2024
| Organisation | Akums Drugs & Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Akums Drugs & Pharmaceuticals Ltd
Akums Drugs Shares Rise on Buy Call from Ambit - 08 Jan, 2025
Akums Drugs shares surged 4% after Ambit initiated a Buy rating with a target price of Rs 840, citing growth potential in India's pharmaceutical sector despite current earnings weakness.Akums Launches New Sterile Manufacturing Facility - 02 Jan, 2025
Akums Drugs and Pharmaceuticals has operationalized a new sterile facility for lyophilized products and injectables, targeting the growing global demand in this niche market. The facility aims to enhance production capabilities and meet therapeutic needs, with the global lyophilised injectables market projected to grow significantly by 2030.Akums Secures Major European Partnership Amid Profit Decline - 27 Dec, 2024
Akums Drugs & Pharmaceuticals announced a strategic 200 million euro partnership for European drug formulations, leading to an 8% share price increase despite a profit decline.Akums Drugs Secures Major European CDMO Agreement - 24 Dec, 2024
Akums Drugs has entered a ₹1,760 crore CDMO agreement with a leading global pharma company to supply oral liquid formulations in Europe, starting in 2027. The deal includes an upfront payment of ₹880 crore and aims to expand Akums' presence in regulated markets.
Insights on Akums Drugs & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 5.18% to 5.54% in Dec 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, AKUMS stock has moved up by 4.2%
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 7.15% to 8.65% in Dec 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 75.26% of holdings in Dec 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 7.34% to 6.36% in Dec 2024 quarter
Akums Drugs & Pharmaceuticals Ltd Financials
Index Inclusions
Akums Drugs & Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 75.26% | 0.00 | |
| Foreign Institutions | 6.36% | ||
| Mutual Funds | 5.54% | 7.08 | |
| Retail Investors | 8.65% | 21.03 | |
| Others | 4.18% |
Akums Drugs & Pharmaceuticals Ltd Key Indicators
Akums Drugs & Pharmaceuticals Ltd Valuation
Akums Drugs & Pharmaceuticals Ltd in the last 5 years
Lowest (28.76x)
November 18, 2024
Today (32.90x)
January 17, 2025
Industry (54.95x)
January 17, 2025
Highest (65.57x)
August 19, 2024
Akums Drugs & Pharmaceuticals Ltd Earnings and Dividends
Akums Drugs & Pharmaceuticals Ltd Earnings Results
Akums Drugs & Pharmaceuticals Ltd’s net profit jumped 105% since last year same period to ₹65.21Cr in the Q2 2024-2025. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated 8.38% jump in its net profits since last 3-months.
Read More about Earnings Results
Akums Drugs & Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Akums Drugs & Pharmaceuticals Ltd is currently in a Neutral trading position according to technical analysis indicators.
FAQs on Akums Drugs & Pharmaceuticals Ltd
Akums Drugs & Pharmaceuticals Ltd share price today stands at ₹623.85, Open. ₹623.85 ; Previous Close. ₹632.7 ; High. ₹634.95 ; Low. ₹621.15 ; 52 Week High. ₹1175.9 ; 52 Week Low: ₹530.05.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Akums Drugs & Pharmaceuticals Ltd shares.
Akums Drugs & Pharmaceuticals Ltd is listed on NSE
Akums Drugs & Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Akums Drugs & Pharmaceuticals Ltd is ₹634.95.
- Today’s lowest price of Akums Drugs & Pharmaceuticals Ltd is ₹621.15.
PE Ratio of Akums Drugs & Pharmaceuticals Ltd is 32.9
PE ratio = Akums Drugs & Pharmaceuticals Ltd Market price per share / Akums Drugs & Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Akums Drugs & Pharmaceuticals Ltd(AKUMS) is 81.85K.
Today’s market capitalisation of Akums Drugs & Pharmaceuticals Ltd(AKUMS) is ₹9958.32Cr.
| Akums Drugs & Pharmaceuticals Ltd(AKUMS | Price |
|---|---|
52 Week High | ₹1175.9 |
52 Week Low | ₹530.05 |
Akums Drugs & Pharmaceuticals Ltd(AKUMS) share price is ₹623.85. It is down -46.95% from its 52 Week High price of ₹1175.9
Akums Drugs & Pharmaceuticals Ltd(AKUMS) share price is ₹623.85. It is up 17.70% from its 52 Week Low price of ₹530.05
| Akums Drugs & Pharmaceuticals Ltd(AKUMS | Returns |
|---|---|
1 Day Returns | -8.85% |
1 Month Returns | 10.46% |
3 Month Returns | -30.91% |
1 Year Returns | -20.54% |